Official account of the RAINBO program of 4 clinical trials for women with endometrial cancer. Email: [email protected]
International
Joined September 2022
- Tweets25
- Following217
- Followers222
- Likes95
Another 🌈 RAINBO trial has opened for accrual! The 🍅 p53abn-RED trial has included its 1st patient in France. In this trial, led by dr. Leary, the benefit of the addition of a PARP-i to chemoradiation is investigated in women with invasive stage I-III p53abn endometrial cancer
open.spotify.com/episode/6nl…
The podcast on the design of the RAINBO program and the RED, GREEN, ORANGE and BLUE trials with prof. Creutzberg, dr. Leary and dr. Horeweg is now available on Spotify
Junior principal investigator @Merve_Kaya___ presents the design of the 🌈RAINBO MMRd-GREEN trial at #ASCO23
A phase III trial investigating the addition of durvalumab to pelvic RT in women with stage IB/II (with substantial LSVI) and stage III MMRd endometrial cancer
Congratulations @helenwhite100 Your outstanding work has given women with womb cancer a voice and created a bridge with scientists. We are proud and happy to have you in our Advisory Committee.
The RAINBO Core Group consists of Carien Creutzberg (Chair) Alexandra Leary (PI RED), Judith Kroep (PI GREEN), @DrMelaniePowell & @ProfEmmaCrosbie (PIs ORANGE), Kathy Han & Jessica McAlpine (PIs BLUE), Nanda Horeweg (overarching coordinator) and Tjalling Bosse (translational lead
RAINBO Research Consortium retweeted
A very interesting podcast about the #RAINBOtrial 🌈 congratulations to these amazing women!!👏🏽👏🏽 – at Miranda, Venezuela
Today, the #WeeklyPodcast is full of colors
Drs Carien Creutzberg, @NandaHoreweg & Alexandra Leary discussed the #RAINBOtrials @RAINBOprogram🌈@LUMC_Leiden
🎙️bit.ly/423EJIG
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official
Representatives of the RAINBO Consortium joined @pedroramirezMD for the podcast of @IJGConline to discuss our 4 clinical trials and answering interesting questions from the @IJGCfellows Thank you for this opportunity and looking forward to the release of the recording. ❤️💚🧡💙
RAINBO Research Consortium retweeted
#2023SpecialIssue
Update in the #MolecularClassification of #EndometrialCarcinoma 🧬
🔗 bit.ly/40cXnh1
@AliciaLenCasti1 @pedroramirezMD @HsuMd @agz_eriksson @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @OncoAlert @IJGCfellows @GynMe4
The TransPORTEC study that informed the design of the NSMP-ORANGE trial for women with high-risk NSMP endometrial cancer is out.
Read the paper by Lisa Vermij et al. in Br J Cancer. rdcu.be/c30t3 @ProfEmmaCrosbie
RAINBO Research Consortium retweeted
#ClinicalTrial Refining adjuvant treatment in #endometrialcancer based on molecular features: the #RAINBO clinical trial program 🌈 #MolecularClassification @RAINBOprogram
👉 bit.ly/3ZgR9Nl
@pedroramirezMD @agz_eriksson @HsuMd @JayrajAarthi @AndreFernandes2
ALT Inclusion algorithm of the RAINBO program. Assessment of the molecular classification must be performed according to the World Health Organization 2020 classification of endometrial cancer.
ALT Sample size of the RAINBO clinical trials and overarching research program.
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program ijgc.bmj.com/content/33/1/10…
RAINBO Research Consortium retweeted
Proud to co-lead the @RAINBOprogram ORANGE trial with @DrMelaniePowell on behalf of an incredible international consortium with Carien Creutzberg, Tjalling Bosse, Judith Kroep, Alexandra Leary, Jessica McAlpine, Kathy Han, Nanda Horeweg & Team
ijgc.bmj.com/content/33/1/10…
RAINBO Research Consortium retweeted
The #RAINBOprogram 🌈 will allow us to demonstrate the benefits of the molecular classification of #endometrialcancer over adjuvant treatment. 🫶🏽🧬🫶🏽
Our paper describing the design of the RAINBO program is published! Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO program of 4 clinical trials ijgc.bmj.com/content/33/1/10…
Thank you to @IJGConline @pedroramirezMD @Frumovitz
Our paper describing the design of the RAINBO program is published! Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO program of 4 clinical trials ijgc.bmj.com/content/33/1/10…
Thank you to @IJGConline @pedroramirezMD @Frumovitz
The work of dr. Alicia Léon on the molecular classification of endometrial cancer changed the way we diagnose and treat this disease. She successfully defended her PhD thesis last week in Leiden, the Netherlands.
Two days ago Alicia Léon successfully defended her PhD thesis which was fundamental to the design of the RAINBO program and changed the way we diagnose and treat women with endometrial cancer today. Congratulations from the RAINBO research consortium!
RAINBO Research Consortium retweeted
Targeted Molecular testing in #endometrial #cancer paper is out. The number of POLE tests can be reduced by up to 40%. Great collaboration with the UBC team and Dr. Naveena Singh. Read more about it here:
tinyurl.com/2pmfhesv
ALT Targeted testing algorithm
Prof. Carien Creutzberg gives an excellent presentation on the endometrial cancer molecular classes and their application in the RAINBO program at #ESGO2022 in Berlin #CancerResearch
The RAINBO program is a platform of 4 international clinical trials on novel personalised therapies for women with endometrial cancer. Details on its design and current status are available at:
clinicaltrials.gov/ct2/show/…
#CancerResearch #wombcancer #clinicaltrials
